Acute symptomatic occlusion of the cervical internal carotid artery (ICA) can be treated by intravenous administration of tissue plasminogen activator, percutaneous transluminal angioplasty, and carotid endarterectomy. Carotid artery stenting (CAS) is now indicated for cervical ICA stenosis, but the safety and the efficacy of urgent CAS have not been established. We retrospectively reviewed 10 patients treated by urgent CAS for atherosclerotic occlusive lesions of cervical ICA with acute stroke. Five patients had complete occlusions and five had near total occlusions. Five of the 10 patients had intracranial tandem occlusions. Indication for urgent CAS was determined by mismatch of diffusion-weighted and perfusion-weighted magnetic resonance imaging findings. Stents were successfully deployed in all lesions. Three of five patients with concomitant intracranial tandem occlusions were treated by additional intraarterial fibrinolysis after the CAS. Intracranial artery occlusions were completely recanalized in one patient, and partially recanalized in two by fibrinolysis. Hyperperfusion syndrome did not occur in any of the patients. A favorable outcome (modified Rankin Scale Ã1) was obtained in all of the five patients with isolated cervical ICA occlusion and one of the five patients with intracranial tandem occlusions. Urgent CAS is a safe and effective treatment in patients with isolated cervical ICA occlusion. Treatment of intracranial tandem occlusions is an issue that must be resolved.
Introduction
The natural history of acute cervical internal carotid artery (ICA) occlusion with serious neurological symptoms is unfavorable. 1) Treatment for acute symptomatic occlusion of the cervical ICA includes intravenous administration of tissue plasminogen activator (tPA), percutaneous transluminal angioplasty, and carotid endarterectomy (CEA). Intravenous administration of tPA results in complete recanalization and favorable outcome in 10% and 44% of cases of intra-and extracranial ICA occlusion, respectively. 4) Emergency CEA is effective for progressing and fluctuating stroke but not for severe completed stroke due to the narrow therapeutic window. 7, 12) Recently, the safety and efficacy of carotid artery stenting (CAS) in the chronic stage have been established. 3, 17) However, CAS in the acute stage remains challenging because of the limited therapeutic window and risk of hyperperfusion syndrome or hemorrhagic infarction after revascularization. 8) This retrospective study investigated the safety, efficacy, and limitations of urgent CAS.
Materials and Methods
Ten male patients aged 70-87 years (mean 77.3 yrs) with acute stroke related to atherosclerotic cervical ICA occlusion were treated by urgent CAS beginning in 2001. The diagnosis was differentiated from cardiogenic embolism in the absence of atrial fibrillation or cardiac valvular disease and tapered occlusion of ICA by angiography, and confirmed by the balloon configuration during inflation and features of residual stenosis after predilation. An- (Table 1) . Patients with serious neurological symptoms, such as disturbance of consciousness, severe hemiparesis, and aphasia, were candidates for urgent CAS. All patients were examined by computed tomography, followed by magnetic resonance (MR) imaging. The indication for urgent CAS was determined by mismatch between the diffusion-weighted MR imaging finding of either localized or absence of high intensity area and the perfusion-weighted MR imaging finding of decreased cerebral blood flow related to the occluded ICA. 8, 9) Urokinase (240 000 U) was injected intravenously before angiography. Aspirin (200 mg) and ticlopidine (100 mg) or cilostazol (100 mg) were also administered. Fourvessel angiography was performed to estimate collateral flow from the anterior and posterior communicating arteries, and to determine the presence of concomitant intracranial artery occlusion.
After diagnostic angiography, heparin (4000 U) was injected intraarterially and activated clotting time of 200-250 seconds was maintained. An 8F or 9F guiding catheter was inserted in the common carotid artery. A 0.014-inch or 0.018-inch microwire was then passed through the lesion. If this was not possible, a 0.035-inch guidewire was used. A protective device (PercuSurge GuardWire; Medtronic Inc., Minneapolis, Minn., U.S.A.) was used in the later five patients to prevent distal embolism. After inserting the guidewire through the lesion, predilation was performed. Stent size was determined by angiography after predilation. Stenting and postdilation were then performed. The stents used were NIR (Boston Scientific, Natick, Mass., U.S.A.) in one patient, SMART (Cordis Endovascular, Miami Lakes, Fla., U.S.A.) in six, and PRECISE (Cordis Endovascular) in three. Intraarterial fibrinolysis (IAF) was performed using urokinase (240 000-480 000 U) in three of the five patients with intracranial artery occlusions ( Table 2) . Systolic blood pressure was strictly controlled under 120 mmHg after revascularization.
Clinical symptoms and outcomes were estimated with the modified National Institutes of Health Stroke Scale (mNIHSS) before and on the 30th day, and modified Rankin Scale (mRS) on the 90th day after the procedure.
Results
Stents were successfully deployed in all lesions. Passing the guidewire and predilation balloon through the occluded segment presented some difficulties, but was possible in all patients. The Urgent CAS length of the lesions was disclosed after the predilation, and none extended to the petrous portion of the ICA. After predilation was accomplished, stent deployment was uneventful. A clot was aspirated in one of the five patients in whom distal blocking balloons were used. Duration between the onset (deterioration of symptoms in patients of progressing stroke) and the stenting was 3 to 24 hours (mean 7.2 hrs). IAF for three patients with intracranial tandem occlusion achieved complete recanalization in one patient (Case 6, Fig. 1 ), and partial recanalization in two patients. Diffusion-weighted MR imaging showed a large infarction in the territory of the occluded arteries in the patients whose intracranial artery occlusions were not recanalized.
The median mNIHSS score at 30 days improved from 10.5 to 3.7, and favorable outcome of mRS at 90 days Ã1 was obtained in six of the 10 patients. All patients without intracranial tandem occlusion achieved good recovery. On the other hand, favorable outcome was obtained in only one patient with intracranial tandem occlusion. Preoperative mNIHSS score Ã10 was related to a favorable outcome. One patient (Case 7), who had middle cerebral artery (MCA) occlusion and did not undergo IAF, died of a large infarction in the MCA distribution. One patient (Case 3), in whom a blocking device was not used, suffered distal embolism resulting in deterioration of hemiparesis. No patient developed hyperperfusion syndrome or hemorrhagic infarction (Tables 2 and 3) .
Discussion
Information about the distal site of the occlusion is important for determining the strategy for the treatment of acute ICA occlusion. Angiography using a microcatheter, which is passed through the lesion, is useful for estimating the length of the lesion, and the presence of thrombi or intracranial tandem lesions. If thrombi are located distal to the lesion, revascularization may result in distal embolism. Moreover, thrombi lodged at the ICA terminal or MCA may decrease collateral flow from the anterior and posterior communicating arteries, and cause deterioration of the symptoms. In such cases, use of a proximal blocking system is necessary. 
N. Miyamoto et al.
The present study showed that favorable outcome in patients treated with urgent CAS for cervical ICA occlusion was related to progressing stroke, mNIHSS score Ã10 before treatment, and absence of intracranial tandem occlusions (Table 3) . We considered that the unfavorable outcomes in patients with intracranial tandem occlusions were caused by failure of revascularization of the intracranial artery within the time window despite successful recanalization of the cervical ICA by CAS.
Revascularization of acute cervical ICA occlusion is still controversial because of the risk of hyperperfusion syndrome or hemorrhagic infarction. The diffusion-weighted/perfusion-weighted MR imaging mismatch indicative of ischemic penumbra is useful for the selection of patients who might benefit from recanalization. 2, 14) However, successful recanalization does not always result in a favorable outcome because of the time lag between MR imaging and recanalization. Therefore, the indication for revascularization in patients with intracranial tandem occlusions must be limited because of the narrow time window that occurs with less collateral flow. On the other hand, patients with isolated ICA occlusion or with progressing stroke may have a wider time window, because of significant collateral flow from the anterior communicating artery, posterior communicating artery, and external carotid artery.
Cervical ICA occlusion is associated with a high incidence of intracranial tandem occlusions. We think that thrombus adhering to ruptured plaque, which is the usual cause of acute occlusion of the cervical ICA, also causes distal embolism. 11) Residual antegrade flow in patients with near total ICA occlusion is likely to dislodge and transport the thrombus into the distal ICA distribution. In our series, intracranial tandem occlusion was observed in four of the five patients with complete ICA occlusion. Mechanisms of intracranial artery occlusion associated with complete ICA occlusion are as follows: intracranial artery occlusion followed by cervical ICA occlusion; complete occlusion and partial recanalization repeatedly occurring in the acute occlusive lesion of the cervical ICA; and thrombus formed in the stagnant ICA stump (ICA terminal) migrating to the MCA by collateral flow (Fig. 2) .
Revascularization of intracranial artery occlusion by IAF requires much time, but the therapeutic time window is narrow compared with that for isolated cervical ICA occlusion. To achieve rapid recanalization of tandem occlusions, intravenous tPA administration may be beneficial. However, the recanalization rate of tandem ICA/MCA occlusions by intravenous tPA administration is only 9%. 10) Moreover, a considerable degree of residual stenosis will persist even if recanalization can be obtained. Therefore, additional CEA or CAS will be required to prevent recurrent stroke. The combination of intravenous tPA administration prior to endovascular intervention and urgent CAS/IAF may facilitate rapid recanalization of the intracranial artery, but may also increase the risk of hemorrhagic infarction. 9) Our limited experience suggests that CAS in the acute stage is not difficult compared to the chronic stage. We experienced symptomatic distal embolism in one patient in whom no protective device was used. CAS for cervical ICA occlusion in the acute stage, in which thrombus adheres to plaque, has a higher risk of distal embolism than in the chronic stage. Therefore, protective devices should be used. 6, 16) We employed a distal blocking method using a balloon (PercuSurge GuardWire) in the later five patients, which could be passed through all lesions. Use of a Parodi Anti-Embolic system (ArteriA, San Francisco, Calif., U.S.A.), which can prevent distal embolism through all procedures, is recommended although the procedures are complicated and sufficient back flow cannot be obtained in patients with poor collateral flow.
Urgent CAS carries the risk of reperfusion injury such as hyperperfusion syndrome or hemorrhagic transformation. The incidence of hyperperfusion syndrome after CAS is 5% to 7%. 5, 13) To prevent this complication, strict postoperative control of blood pressure is most important. Staged treatments are recommended to minimize the risk of reperfusion injury. 15) Patients underwent urgent, intentionally partial recanalization of the occluded ICA with percutaneous transluminal angioplasty/stent placement, together with IAF of the intracranial artery through the occluded ICA. Complete recanalization was achieved either with repeated endovascular treatment or with CEA in a delayed fashion. In contrast, our strategy aims to achieve complete recanalization by a single intervention. Hyperperfusion syndrome did not occur in our series nor in the 25 patients in a previous series. 9) However, hyperperfusion occurred in three of 17 patients (one symptomatic putaminal hemorrhage and two asymptomatic subarachnoid hemorrhage). 8) We believe that the low incidence of hyperperfusion syndrome after urgent CAS is acceptable.
Urgent CAS is a safe and effective treatment in patients with isolated cervical ICA occlusion. Treatment of intracranial tandem occlusions is an issue that must be resolved to achieve a favorable outcome.
Commentary
This interesting paper describes a potentially useful technique in patients with acute stroke and cervical internal carotid artery (ICA) occlusion. In their 10 cases treated with urgent ICA stenting there were some technical difficulties, but the procedure could be completed in all. There were no complications apart from distal embolism in one patient -in later cases a distal blocking balloon was used to minimize this risk. Importantly, there was no episode of hemorrhagic infarction or hyperperfusion syndrome after reperfusion, and the need for careful blood pressure control is rightly stressed.
It is noteworthy that good outcomes were seen only in patients with an isolated cervical ICA occlusion. This emphasizes the difficulty of achieving good outcomes where there are tandem lesions with intracranial occlusions; as discussed, there is often not
